Article History
Received: 25 August 2021
Accepted: 27 September 2021
First Online: 8 November 2021
Declarations
:
: All Guideline Task Force members were required to disclose all potential COIs prior to beginning work on the guideline, using the COI disclosure form of the AANS/CNS Joint Guidelines Review Committee. The CNS Guidelines Committee and Guideline Task Force Chair reviewed the disclosures and either approved or disapproved the nomination and participation on the task force. The CNS Guidelines Committee and Guideline Task Force Chair may approve nominations of task force members with possible conflicts and restrict the writing, reviewing, and/or voting privileges of that person to topics that are unrelated to the possible COIs. The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this series of articles.
: These guidelines were funded exclusively by the Congress of Neurological Surgeons (CNS) and the Joint Section on Tumors, which received no funding from outside commercial sources to support the development of this document.